BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15842433)

  • 1. Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram.
    Husser D; Binias KH; Stridh M; Sornmo L; Olsson SB; Molling J; Geller C; Klein HU; Bollmann A
    Ann Noninvasive Electrocardiol; 2005 Apr; 10(2):206-10. PubMed ID: 15842433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.
    Hesselkilde EZ; Carstensen H; Haugaard MM; Carlson J; Pehrson S; Jespersen T; Buhl R; Platonov PG
    BMC Cardiovasc Disord; 2017 Dec; 17(1):289. PubMed ID: 29221440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.
    Bollmann A; Binias KH; Toepffer I; Molling J; Geller C; Klein HU
    Am J Cardiol; 2002 Nov; 90(9):1011-4. PubMed ID: 12398975
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
    Wang Z; Pagé P; Nattel S
    Circ Res; 1992 Aug; 71(2):271-87. PubMed ID: 1628386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.
    Limantoro I; De Vos CB; Delhaas T; Marcos E; Blaauw Y; Weijs B; Tieleman RG; Pisters R; Schotten U; Van Gelder IC; Crijns HJ
    Heart Rhythm; 2014 Mar; 11(3):478-84. PubMed ID: 24321238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model.
    Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L
    Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
    Capucci A; Piangerelli L; Ricciotti J; Gabrielli D; Guerra F
    Europace; 2016 Nov; 18(11):1698-1704. PubMed ID: 26893497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation.
    Husser D; Stridh M; Sornmo L; Geller C; Klein HU; Olsson SB; Bollmann A
    Am J Cardiol; 2005 Feb; 95(4):526-8. PubMed ID: 15695146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of flecainide on the electrophysiological properties of atrial vulnerability in humans.
    Yoshiga Y; Shimizu A; Yamagata T; Esato M; Ueyama T; Ohmura M; Itagaki K; Kimura M; Kakugawa H; Doi M; Matsuzaki M
    Circ J; 2003 May; 67(5):437-42. PubMed ID: 12736484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG.
    Bollmann A; Sonne K; Esperer HD; Toepffer I; Klein HU
    Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):92-7. PubMed ID: 12049679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation.
    Tessarolo Silva F; Pedreira GC; Medeiros SA; Bortolotto AL; Araujo Silva B; Hurrey M; Madhavapeddi P; Schuler C; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):205-213. PubMed ID: 31749267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation.
    Kalifa J; Bernard M; Gout B; Bril A; Cozma D; Laurent P; Chalvidan T; Deharo JC; Djiane P; Cozzone P; Maixent JM
    Cardiovasc Drugs Ther; 2007 Feb; 21(1):47-53. PubMed ID: 17356910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making.
    Bollmann A; Husser D; Stridh M; Soernmo L; Majic M; Klein HU; Olsson SB
    J Cardiovasc Electrophysiol; 2003 Oct; 14(10 Suppl):S154-61. PubMed ID: 14760918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation.
    Bollmann A; Husser D; Stridh M; Holmqvist F; Roijer A; Meurling CJ; Sörnmo L; Olsson SB
    Europace; 2007 Aug; 9(8):621-6. PubMed ID: 17604306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation.
    Husser D; Stridh M; Sörnmo L; Roden DM; Darbar D; Bollmann A
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):24-8. PubMed ID: 19305639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.